![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CJ Van Koppen, D Meyer Zu Heringdorf, C Zhang, KT Laser and KH Jakobs
Institut fur Pharmakologie, Universitat GH Essen, Germany. van_koppen@uni-essen.de
The sphingolipids, sphingosylphosphorylcholine (SPPC) and sphingosine-1- phosphate (SPP), induce a rapid and transient rise in intracellular free calcium concentration ([Ca2+]i) in a variety of cell lines via activation of pertussis toxin-sensitive G protein-coupled receptors. We investigated whether these sphingolipids act on different receptors by testing the effect of varying concentrations of SPPC on [Ca2+]i in human leukemia HL-60 cells, which have been found to be nonresponsive to SPP. SPPC potently (EC50 = 1.5 microM) and rapidly increased [Ca2+]i in HL-60 cells in a pertussis toxin-sensitive manner. Differentiation of HL-60 cells through treatment with dibutyryl cAMP into granulocyte- like cells did not change the magnitude or the pertussis toxin sensitivity of the SPPC-induced [Ca2+]i rise, indicating that the receptor for SPPC is constitutively expressed in HL-60 cells. SPPC did not activate phospholipase C or D in HL-60 cells. However, SPPC, but not SPP, stimulated the generation of superoxide anions in dibutyryl cAMP-differentiated HL-60 cells as well as in human neutrophils, suggesting that the SPPC receptor may play a role in the inflammatory defense against invading microorganisms. On the basis of these results, we conclude that there apparently is a heterogeneity of G protein- coupled receptors for sphingolipids in mammalian cells.
This article has been cited by other articles:
|
|
 |
|
  Y. Xu, Y.-j. Xiao, L. M. Baudhuin, and B. M. Schwartz The Role and Clinical Applications of Bioactive Lysolipids in Ovarian Cancer Reproductive Sciences, January 1, 2001; 8(1): 1 - 13. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Alemany, B. Sichelschmidt, D. M. zu Heringdorf, H. Lass, C. J. van Koppen, and K. H. Jakobs Stimulation of Sphingosine-1-phosphate Formation by the P2Y2 Receptor in HL-60 Cells: Ca2+ Requirement and Implication in Receptor-Mediated Ca2+ Mobilization, but Not MAP Kinase Activation Mol. Pharmacol., September 1, 2000; 58(3): 491 - 497. [Abstract] [Full Text]
|
|
|
|
|
|
H. M. Himmel, D. Meyer zu Heringdorf, E. Graf, D. Dobrev, A. Kortner, S. Schüler, K. H. Jakobs, and U. Ravens Evidence for Edg-3 Receptor-Mediated Activation of IK.ACh by Sphingosine-1-Phosphate in Human Atrial Cardiomyocytes Mol. Pharmacol., August 1, 2000; 58(2): 449 - 454. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Alemany, D. Meyer zu Heringdorf, C. J. van Koppen, and K. H. Jakobs Formyl Peptide Receptor Signaling in HL-60 Cells through Sphingosine Kinase J. Biol. Chem., February 12, 1999; 274(7): 3994 - 3999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wenzel-Seifert, C. M. Hurt, and R. Seifert High Constitutive Activity of the Human Formyl Peptide Receptor J. Biol. Chem., September 11, 1998; 273(37): 24181 - 24189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Himmel, D. M. z. Heringdorf, B. Windorfer, C. J. v. Koppen, U. Ravens, and K. H. Jakobs Guanine Nucleotide-Sensitive Inhibition of L-Type Ca2+ Current by Lysosphingolipids in RINm5F Insulinoma Cells Mol. Pharmacol., May 1, 1998; 53(5): 862 - 869. [Abstract] [Full Text]
|
|
|
|
|
|
A. Titievsky, I. Titievskaya, M. Pasternack, K. Kaila, and K. Tornquist Sphingosine Inhibits Voltage-operated Calcium Channels in GH4C1 Cells J. Biol. Chem., January 2, 1998; 273(1): 242 - 247. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
